Skip to main content

Oribel Capital Management, LP

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1661140 NEW YORK, NY

Position in TMO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,926,928
-$9,667,880 QoQ
Shares Held
19,800
-51.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#647
of 2,606 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Derivatives in TMO

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$9,926,928
PutShares
19,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Oribel Capital Management, LP holds $26,967,879 across 2 Diagnostics & Research names. TMO ranks #2 (36.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 TMO
Thermo Fisher Scientific Inc.
This page
19,800 $9,926,928

All Filings in TMO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,926,928 19,800
2026-06-30 $9,926,928 19,800
2025-09-30 $19,594,808 40,400
2025-09-30 $19,594,808 40,400
2025-09-30 $49,472,040 102,000
2025-03-31 $20,998,720 42,200
2024-12-31 $24,658,902 47,400
2024-12-31 $24,658,902 47,400
2024-09-30 $46,578,321 75,300
2024-06-30 $200,910 54,300
2024-03-31 $11,914,805 20,500
2023-12-31 $59,554,638 112,200
2023-06-30 $21,026,525 40,300
2022-12-31 $13,877,388 25,200
2022-12-31 $13,877,388 25,200
2022-09-30 $6,948,503 13,700
2022-06-30 $7,008,312 12,900
2021-12-31 $31,827,348 47,700
2021-12-31 $31,827,348 47,700